This is unpublished

Mary
Flowers
M.D.

she, her, hers
Physician & Research Faculty
Pinned
Academic
Professor, Clinical Research Division, Fred Hutchinson Cancer Research Center
Professor, Division of Medical Oncology, University of Washington
Sites of Practice
Seattle Cancer Care Alliance

Photo: Fred Hutch

Education, Training, Board Certifications

  • M.D., Universidade Federal do Rio Grande do Norte, Natal, Brazil 
  • Residency in Hematology, Instituto Estadual de Hematolgia A.S.C., Brazil 
  • Fellowship in Medical Oncology, University of Colorado Health Sciences Center
  • Fellowship in Hematology-Oncology, UW
  • Board Certified in Hematology, Pontifícia Universidade Catolica do Rio de Janeiro, Rio de Janeiro, Brazil

Clinical Expertise   

  • Hematopoietic stem cell transplantation (HSCT)
  • Chronic graft-versus-host disease
  • HSCT survivorship and long-term follow-up care model

Affiliations 

 

Publications

 

Research and/or clinical interests 

Dr. Mary Flowers’ clinical research has focused on long-term outcomes after hematopoietic cell transplantation (HCT), with particular attention to studies of chronic graft-versus-host disease (GVHD), quality of life and other late events. Her research spans from clinical trials to registry studies to cohort studies. She has been the principal investigator or co-investigator in several interventional clinical trials including multicenter randomized studies in chronic GVHD. Dr. Flowers is a world-renowned expert in the treatment of chronic graft-vs-host disease. She has been an advocate for providing the highest quality survivorship care for transplant survivors and their families, and works closely with primary care physicians to manage post-transplant complications as patients recover and resume their lives. Dr. Flowers’ contributions to the HCT survivorship field have reached national and global arenas, including training of a multi-disciplinary team.